$24.97
0.69% yesterday
Nasdaq, Apr 25, 10:00 pm CET
ISIN
US09062W2044
Symbol
BLFS

BioLife Solutions, Inc. Stock price

$24.96
-0.87 3.35% 1M
+2.93 13.28% 6M
-1.01 3.87% YTD
+8.10 48.01% 1Y
+11.17 80.96% 3Y
+13.73 122.22% 5Y
+23.00 1,173.21% 10Y
Nasdaq, Closing price Fri, Apr 25 2025
+0.16 0.63%
ISIN
US09062W2044
Symbol
BLFS
Sector

Key metrics

Market capitalization $1.19b
Enterprise Value $1.11b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 213.64
EV/Sales (TTM) EV/Sales 9.80
P/S ratio (TTM) P/S ratio 10.46
P/B ratio (TTM) P/B ratio 3.35
Revenue growth (TTM) Revenue growth -20.89%
Revenue (TTM) Revenue $113.34m
EBIT (operating result TTM) EBIT $-16.36m
Free Cash Flow (TTM) Free Cash Flow $5.20m
Cash position $104.58m
EPS (TTM) EPS $-0.26
P/E forward negative
P/S forward 12.22
EV/Sales forward 11.45
Short interest 11.12%
Show more

Is BioLife Solutions, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

BioLife Solutions, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a BioLife Solutions, Inc. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a BioLife Solutions, Inc. forecast:

Buy
100%

Financial data from BioLife Solutions, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
113 113
21% 21%
100%
- Direct Costs 59 59
42% 42%
52%
55 55
31% 31%
48%
- Selling and Administrative Expenses 53 53
22% 22%
47%
- Research and Development Expense 9.88 9.88
47% 47%
9%
-8.14 -8.14
82% 82%
-7%
- Depreciation and Amortization 8.22 8.22
36% 36%
7%
EBIT (Operating Income) EBIT -16 -16
72% 72%
-14%
Net Profit -11 -11
83% 83%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about BioLife Solutions, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioLife Solutions, Inc. Stock News

Neutral
PRNewsWire
19 days ago
Strategic acquisition enhances biopreservation media portfolio with novel Ice Recrystallization Inhibitor technology Marks the second acquisition from Bioproduction Innovation Accelerator program BOTHELL, Wash. , April 7, 2025 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS ) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the ce...
Positive
Seeking Alpha
20 days ago
BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has consistently exceeded earnings expectations, indicating strong future potential and investor confidence. BioLife's unique focus on cell preservation and storage positions it advantageously within the...
Neutral
PRNewsWire
about one month ago
BOTHELL, Wash. , March 18, 2025 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS ) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the appointment of Cathy Coste to its board of directors, increasing board membership to seven.
More BioLife Solutions, Inc. News

Company Profile

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Head office United States
CEO Roderick Greef
Employees 159
Founded 1987
Website www.biolifesolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today